Project Grant 2528240
Award Date 10/1/25
Completion Date 9/30/26
Dollars Obligated $305K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32653, USA
Similar Awards
- This STTR Phase I project, funded by the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a novel bioactive hydrogel dressing with a porous surface for the treatment of second-degree burn wounds. The $305,000 award to LF Printech LLC, a minority-owned, for-profit small business, seeks to address the critical challenges in burn wound management by creating a dressing that can accelerate natural healing processes, reduce pain...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Therapeutic Bandage Products, Inc. will develop an advanced wound care product to speed healing of diabetic foot ulcers. The patented microneedle patch design will deliver three therapeutic agents to the wound site - an antibiotic to kill bacteria, an agent to prevent biofilm reformation, and a chemokine to activate white blood cells for cleanup. This product aims to...
- This Project Grant award, made by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of Dermisphere, an advanced dermal regeneration scaffold product by Fesariustherapeutics Inc. The $349,345 award aims to demonstrate the feasibility of using Dermisphere to manage acute major burn wounds. Preliminary studies have shown that Dermisphere can support rapid and sustained cellular...
- This $100,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program will support the development of an advanced wound care technology at Florida International University. Specifically, the university will create a bandage-integrated platform that provides feedback-mediated wound therapy to enable personalized care. The conformable platform is designed to non-invasively monitor multiple wound biomarkers in spatial detail and then apply targeted...
- The National Science Foundation (NSF) awarded a $275,000 SBIR Phase I Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Auxilium Health, Inc. located in Cleveland, OH. The project aims to develop and validate an aerogel-based wound dressing material platform with mechanical fluid management, biofilm prevention, and real-time pH-based infection detection properties. The innovative dressing material is intended to improve chronic wound care by mitigating...
- The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to develop an automatic debridement device from August 1, 2021 through March 31, 2022. This Small Business Innovation Research Phase I award under the Engineering (47.041) program will support the creation of a product to automatically remove dead, damaged, or infected tissue. The NSF Directorate for Engineering seeks to foster innovation and excellence in engineering research, consistent with...
- This SBIR Phase I project, funded by the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop a microneedle-based platform for the treatment of autoimmune skin diseases. The $304,450 award to Lybra Bio Inc. in Cambridge, MA will advance the hydrogel-based microneedle patch technology to achieve scale-up readiness. The goal is to modulate the drug release profile and determine the minimum wear time required for therapeutic...
- This SBIR Phase I project, funded by the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop an innovative implantable device for treating diabetic foot ulcers (DFUs). The $295,000 grant awarded to Biodynamik, a for-profit small business, will support the design and feasibility testing of a low-profile transverse tibial transport (TTT) implant. This implant leverages the principles of distraction osteogenesis to stimulate soft...
- This $305,000 Phase I Small Business Innovation Research (SBIR) grant awarded by the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) to Limax Biosciences Inc. in Boston, MA aims to develop a novel hemostatic hydrogel adhesive for advanced surgical bleeding control. The project will focus on optimizing the bioinspired HEMOMAX hydrogel, which can achieve adhesion energies 100-1,000 times greater than existing commercial tissue adhesives, to rapidly and...
- Nostopharma LLC was awarded a $256,000 Small Business Technology Transfer Phase I Project Grant from the National Science Foundation to develop a sustained-release, biodegradable nanoparticle drug delivery system for treatment of soft tissue trauma complications. Funded under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the 12-month project beginning March 1, 2022 aims to demonstrate in vitro and in vivo feasibility of modulating the ectopic bone microenvironment...